Sensitivity. Versatility. Reliability.

At OraSure Technologies, we recognize the importance of HIV testing and ensuring that infected people get diagnosed early and linked to care. It is a well known fact that early HIV diagnosis improves patient health outcomes while preventing new infections.

OraQuick ADVANCE® Rapid HIV-1/2 Antibody Test now delivers earlier antibody sensitivity. Our new materials and process improvements have gained critical detection days from initial infection with comparability to 3rd generation automated EIAs.

Delay in days of detection with seroconversion specimens

New performance data demonstrates earlier detection in seroconversion panels when compared to 3rd generation EIA.

OraQuick ADVANCE® Rapid HIV-1/2 Antibody Test was compared against the BioRad GS HIV-1/2 Plus O 3rd Generation automated assay, with over 200 samples across 23 different seroconversion panels. The results are clear.The performance of the OraQuick ADVANCE® Rapid HIV-1/2 Antibody Test is within 1.5 days of 3rd generation testing. This is a significant improvement from our original product launched in 2002.

NEW OraQuick ADVANCE® Rapid HIV-1/2 Antibody Test establishes sensitivity to 3rd generation EIA

It is important to remember that not all tests are created equal. Screening tests like 4th generation automated laboratory assays can detect HIV antibodies approximately 14 days after infection while 3rd generation assays will begin to detect infection approximately 6 days after 4th generation tests. Many of the 2nd generation tests which include a number of the rapid point-of-care tests, do not detect HIV antibodies until 28 days after infection. [ref. CDC]

OraQuick ADVANCE® Rapid HIV-1/2 Antibody Test

the early HIV antibody detection test for recent infection*


  • >99% accurate
  • >99.95% specificity from "Real World" data
  • Comparable to 3rd generation lab-accurate results


  • Ability to batch test
  • Multiple specimen types including oral fluid, fingerstick & venipuncture whole blood, and plasma


  • CLIA-waived
  • Proven performance with over 30 million test worldwide
  • High positive predictive value; minimal false positives

* Refer to the package insert for Warnings and Precautions.